Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Asset Utilization Ratio (2020 - 2025)

Pulmonx (LUNG) reported Asset Utilization Ratio of 0.64 for Q3 2025, up 37.68% year-over-year from 0.47 in Q3 2024, and up 5.65% on a QoQ basis from 0.61 in Q2 2025.

Pulmonx (LUNG) has 6 years of Asset Utilization Ratio data on file, last reported at 0.64 in Q3 2025.

  • Quarterly Asset Utilization Ratio rose 37.68% year-over-year to 0.64 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.64 (up 37.68% YoY) and the FY2024 annual result came in at 0.49, up 33.05% from the prior year.
  • Asset Utilization Ratio advanced to 0.64 in Q3 2025 per LUNG's latest filing, from 0.61 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.64 in Q3 2025 and bottomed at 0.13 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.31 (2023), against an average of 0.35.
  • The widest annual swing landed in 2021, when Asset Utilization Ratio increased 2.79%; it then jumped 69.69% in 2022.
  • Tracing LUNG's Asset Utilization Ratio over 5 years: stood at 0.2 in 2021, then surged by 34.94% to 0.27 in 2022, then jumped by 39.65% to 0.38 in 2023, then surged by 34.03% to 0.51 in 2024, then grew by 26.56% to 0.64 in 2025.
  • Per Business Quant, the three latest LUNG Asset Utilization Ratio figures stand at 0.64 (Q3 2025), 0.61 (Q2 2025), and 0.56 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Pulmonx 67.30 Mn -2.45 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 0.64
Jun 30, 2025 0.61
Mar 31, 2025 0.56
Dec 31, 2024 0.51
Sep 30, 2024 0.47
Jun 30, 2024 0.45
Mar 31, 2024 0.43
Dec 31, 2023 0.38
Sep 30, 2023 0.34
Jun 30, 2023 0.31
Mar 31, 2023 0.29
Dec 31, 2022 0.27
Sep 30, 2022 0.25
Jun 30, 2022 0.24
Mar 31, 2022 0.22
Dec 31, 2021 0.20
Sep 30, 2021 0.18
Jun 30, 2021 0.17
Mar 31, 2021 0.13
Dec 31, 2020 0.20